Company Filing History:
Years Active: 2020
Title: Innovator Seung Han Son: Pioneering Cancer Treatment through Peptide Technology
Introduction: Seung Han Son, an accomplished inventor based in Incheon, South Korea, has made significant strides in the field of cancer treatment. With a focus on developing innovative solutions to combat this widespread disease, he holds a pivotal patent that showcases his expertise and dedication to advancing medical science.
Latest Patents: Seung Han Son's patent is titled "Peptide having anticancer activity, and pharmaceutical composition and dietary supplement composition for preventing and treating cancer". This groundbreaking invention features a peptide that binds to the transcription factor CP2c and is represented by SEQ ID NO: 1: Asn-Tyr-Pro-Gln-Arg-Pro. The peptide demonstrates remarkable stability as it traverses the cell membrane, allowing it to effectively inhibit CP2c’s DNA binding ability. This inhibition disrupts the transcriptional activity specific to cancer cells, highlighting the potential of Son's invention for targeted cancer treatment and prevention.
Career Highlights: Seung Han Son is currently affiliated with the Industry-University Cooperation Foundation at Hanyang University, where he contributes his knowledge and experience to the field of medical research. His commitment to innovation is evident in his work, driving forward the boundaries of cancer research through practical applications of his findings.
Collaborations: Throughout his career, Son has collaborated with fellow researcher Chul Geun Kim, exchanging ideas and knowledge to enhance their contributions to cancer treatment methodologies. Their partnership exemplifies the synergy that can arise from teamwork in academia and industry, fostering advancements in scientific research.
Conclusion: Seung Han Son's innovative approach to developing a peptide for cancer prevention and treatment places him at the forefront of medical innovation. His patent not only represents a significant advancement in cancer therapy but also underscores the importance of collaboration between researchers in academia. As the fight against cancer continues, innovators like Son play a crucial role in developing targeted therapies that could save countless lives.